>Marché du séquençage de l'exome entier en Asie-Pacifique , par composant (séquençage de deuxième génération et séquençage de troisième génération), produit et service (systèmes, kits et services), application ( découverte et développement de médicaments, recherche agricole et animale, diagnostic , médecine personnalisée et autres), utilisateur final (sociétés pharmaceutiques et biotechnologiques , instituts universitaires et de recherche, hôpitaux et cliniques, laboratoires cliniques et autres), canal de distribution (commerce direct, ventes au détail et autres), tendances de l'industrie et prévisions jusqu'en 2029.
Analyse et perspectives du marché
Le marché du séquençage de l'exome entier en Asie-Pacifique devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché connaît une croissance à un TCAC de 18,9 % au cours de la période de prévision de 2022 à 2029. L'augmentation des dépenses et du financement des soins de santé sont les principaux moteurs qui ont propulsé la demande du marché au cours de la période de prévision.
Cependant, les effets secondaires associés aux traitements de séquençage de l'exome entier peuvent entraver la croissance future du marché du séquençage de l'exome entier. L'adoption d'alliances stratégiques telles que les partenariats et les acquisitions par des acteurs clés du marché constitue une opportunité pour la croissance du marché du séquençage de l'exome entier.
Rapport métrique |
Détails |
Période de prévision |
2022 à 2029 |
Année de base |
2021 |
Années historiques |
2020 |
Unités quantitatives |
Chiffre d'affaires en millions USD, prix en USD |
Segments couverts |
Par composant (séquençage de deuxième génération et séquençage de troisième génération), produit et service (systèmes, kits et services), application (découverte et développement de médicaments, recherche agricole et animale, diagnostic, médecine personnalisée et autres), utilisateur final (sociétés pharmaceutiques et biotechnologiques, instituts universitaires et de recherche, hôpitaux et cliniques, laboratoires cliniques et autres), canal de distribution (commerce direct, vente au détail et autres) |
Pays couverts |
Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Malaisie, Thaïlande, Indonésie, Philippines, Vietnam, Reste de l'Asie-Pacifique |
Acteurs du marché couverts |
Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Beckman Coulter, Inc., Eurofins Scientific, BIONEER CORPORATION, ExoDx (une filiale de Bio-Techne), FOUNDATION MEDICINE, INC. (une filiale de F. Hoffmann-La Roche Ltd), GeneFirst Limited, CeGaT GmbH, Meridian, Merck KGaA, SOPHiA GENETICS, Azenta US Inc., CD Genomics, Twist Bioscience, PerkinElmer Genomics (une filiale de PerkinElmer Inc.), GeneDx, LLC, Psomagen, Integrated DNA Technologies, Inc., entre autres. |
Définition du marché du séquençage de l'exome entier
Le séquençage de l'exome entier est une technique génomique permettant de séquencer l'ensemble des régions codantes pour les protéines des gènes d'un génome. Le séquençage de l'exome entier est disponible pour les patients qui recherchent un diagnostic unifié pour plusieurs pathologies. Il s'agit d'un processus de laboratoire utilisé pour déterminer la séquence nucléotidique principalement des régions exoniques (ou codantes pour les protéines) du génome d'un individu et des séquences associées, représentant environ 1 % de la séquence d'ADN complète, également appelée WES. Le séquençage de l'exome entier est une méthode de séquençage de l'exome entier largement utilisée qui consiste à séquencer les régions codantes pour les protéines du génome. L'exome humain représente moins de 2 % du génome, mais contient environ 85 % des variantes connues liées à la maladie, ce qui fait de cette méthode une alternative rentable au séquençage du génome entier.
Le séquençage de l'exome par enrichissement de l'exome permet de détecter efficacement les variantes codantes dans un large éventail d'applications, notamment la génétique des populations, les maladies génétiques et les études sur le cancer. La croissance du marché mondial du séquençage de l'exome entier est attribuée à la réduction du temps et du coût du séquençage. Avec le développement de nouvelles technologies et de traitements contre le cancer, le marché du séquençage de l'exome entier en oncologie clinique a un énorme potentiel dans les années à venir.
Dynamique du marché du séquençage de l'exome entier en Asie-Pacifique
Conducteurs
- Augmentation de l'adoption du séquençage de nouvelle génération (NGS)
Alors que la pharmacologie axée sur la génomique continue de jouer un rôle plus important dans le traitement de diverses maladies chroniques, en particulier le cancer, le séquençage de nouvelle génération (NGS) évolue en tant qu'outil puissant pour fournir un aperçu plus approfondi et plus précis des fondements moléculaires des tumeurs individuelles et des récepteurs spécifiques.
Le NGS offre des avantages en termes de précision, de sensibilité et de rapidité par rapport aux méthodes traditionnelles, qui ont le potentiel d'avoir un impact significatif dans le domaine de l'oncologie. Étant donné que le NGS peut évaluer plusieurs gènes dans un seul test, il n'est plus nécessaire de commander plusieurs tests pour identifier la mutation causale.
- Utilisation croissante des méthodes de séquençage ciblé
Alors que la pharmacologie axée sur la génomique continue de jouer un rôle plus important dans le traitement de diverses maladies chroniques, en particulier le cancer, le séquençage de nouvelle génération (NGS) évolue en tant qu'outil puissant pour fournir un aperçu plus approfondi et plus précis des fondements moléculaires des tumeurs individuelles et des récepteurs spécifiques.
Le NGS offre des avantages en termes de précision, de sensibilité et de rapidité par rapport aux méthodes traditionnelles, qui ont le potentiel d'avoir un impact significatif dans le domaine de l'oncologie. Étant donné que le NGS peut évaluer plusieurs gènes dans un seul test, il n'est plus nécessaire de commander plusieurs tests pour identifier la mutation causale.
Retenue
-
Couverture moins complète des exons
All the exons are not comprehensively captured. The exon of importance may not be included in the current standard annotations of the human genome; and it is merely arduous to cover 100% of the exome with the current WES technology. Consequently, disease-causing variants in these “missed” exons go undetected.
WES has low sensitivity for structural variations, hence detection is limited. Nonetheless some CNVs, including indels and duplications, can be detected by WES, the technical limitation implies that others are likely missed
Opportunity
-
Strategic Initiatives by the key market player
The demand for whole exome sequencing is increasing in the market owing to the increased incidence of genetic disease along with the increased geriatric population across the region. Thus, the top market players have implemented the strategy of collaboration with other market players aimed at improving business operations and profitability.
Challenge
- Ethical and legal issues related to whole exome sequencing
Rapid advances in high throughput genomic technologies and next generation sequencing are making medical genomic research more readily accessible and affordable, including the sequencing of patients and control whole genomes and exomes in order to elucidate genetic factors underlying disease. Progress of high throughput genomic technologies and next generation sequencing (NGS) methods in recent years has changed the scope of human genomic studies. These advances have made it feasible to routinely perform whole exome sequencing studies.
Due to the large-scale, collaborative nature of studies, ethical and legal issues are of increasing concern and have important implications in Africa. African populations are of unique interest because, despite having the highest levels of genetic diversity, living in a vast array of environmental and cultural settings, as well as suffering from a high burden of disease that could be studied using genomics approaches, they are facing legal issues in WES.
Post COVID-19 Impact on Whole Exome Sequencing Market
COVID-19 has resulted in a substantial upsurge in demand for medical supplies from both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the whole exome sequencing market.
Recent Development
- In May, 2022, Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally. This has helped the company to expand its presence.
- In March, 2022, several leading genomics companies and laboratories, including Illumina, Fulgent Genetics, Invitae, GeneDx, and PerkinElmer Genomics, have formed the CardioGenomic Testing Alliance (CGTA), a collaborative group aimed at raising awareness and utilization of genomic testing in cardiology. CGTA seeks to educate healthcare providers and other stakeholders about the value of such testing to assure adherence to existing guidelines from professional medical societies, to inform medical management and cascade testing, and to improve clinical outcomes. This has helped company to adhere to guidelines.
Asia-Pacific Whole Exome Sequencing Market Segmentation
Asia-Pacific whole exome sequencing market is segmented on the basis of component, product and service, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Component
- Second-Generation Sequencing
- Third-Generation Sequencing
On the basis of component, the Asia-Pacific whole exome sequencing market is segmented into second-generation sequencing and third-generation sequencing.
Product and Services
- Systems
- Kits
- Services
On the basis of product and service, the Asia-Pacific whole exome sequencing market is segmented into systems, kits and services.
Application
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- Agriculture & Animal Research
- Others
On the basis of application, the Asia-Pacific whole exome sequencing market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.
End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Clinical Laboratories
- Others
On the basis of end user, the Asia-Pacific whole exome sequencing market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & clinics, clinical laboratories and others.
Distribution Channel
- Direct Trade
- Retail sales
- Others
On the basis of distribution channel, the Asia-Pacific whole exome sequencing market is segmented into direct trade, retail sales and others.
Whole Exome Sequencing Market Country Level Analysis
The whole exome sequencing market is analyzed and market size information is provided by component, product and service, application, end user and distribution channel.
The countries covered in the whole exome sequencing market report are the Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific.
China most dominating due to the presence of key market players along the largest consumer market. China is expected to grow due to the rise in healthcare technological advancement.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Whole exome sequencing market also provides you with detailed market analysis for every country growth in the healthcare industry. Moreover, it provides detailed information regarding healthcare services and treatments, impact of regulatory scenarios, and trending parameters regarding whole exome sequencing market.
Competitive Landscape and Whole Exome Sequencing Market Share Analysis
Whole exome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Whole exome sequencing market.
The major companies which are dealing in the whole exome sequencing market are Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Beckman Coulter, Inc., Eurofins Scientific, BIONEER CORPORATION, ExoDx (a part of Bio-Techne), FOUNDATION MEDICINE, INC. (A subsidiary of F. Hoffmann-La Roche Ltd), GeneFirst Limited, CeGaT GmbH, Meridian, Merck KGaA, SOPHiA GENETICS, Azenta U.S. Inc., CD Genomics, Twist Bioscience, PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.), GeneDx, LLC, Psomagen, Integrated DNA Technologies, Inc., among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS
6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING
6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING
6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION
6.2 RESTRAINTS
6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS
6.2.2 CYBER SECURITY CONCERNS IN GENOMICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING
7 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SECOND-GENERATION SEQUENCING
7.2.1 SEQUENCING BY SYNTHESIS (SBS)
7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL)
7.3 THIRD-GENERATION SEQUENCING
8 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 SYSTEMS
8.2.1 HISEQ SERIES
8.2.1.1 HISEQ 2500
8.2.1.2 HISEQ 1500
8.2.2 MISEQ SERIES
8.2.3 ION TORRENT PLATFORMS
8.2.3.1 ION PROTON
8.2.3.2 ION PGM
8.2.4 OTHERS
8.3 KITS
8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS
8.3.2 LIBRARY PREPARATION KITS
8.3.3 TARGET ENRICHMENT KITS
8.3.4 OTHERS
8.4 SERVICES
8.4.1 SEQUENCING SERVICES
8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES
8.4.3 OTHERS
9 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISCOVERY AND DEVELOPMENT
9.3 AGRICULTURE & ANIMAL RESEARCH
9.4 DIAGNOSTICS
9.5 PERSONALIZED MEDICINE
9.6 OTHERS
10 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 ACADEMIC & RESEARCH INSTITUTES
10.4 HOSPITALS AND CLINICS
10.5 CLINICAL LABORATORIES
10.6 OTHERS
11 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TRADE
11.3 RETAIL SALES
11.4 OTHERS
12 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 INDONESIA
12.1.9 PHILIPPINES
12.1.10 MALAYSIA
12.1.11 VIETNAM
12.1.12 REST OF ASIA-PACIFIC
13 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
14 COMPANY PROFILE
14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.)
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COM PANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COM PANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 EXODX (A PART OF BIO-TECHNE)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COM PANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 THERMO FISHER SCIENTIFIC INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COM PANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COM PANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AZENTA US, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 BECKMAN COULTER, INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BIONEER CORPORATION
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 CD GENOMICS
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 CEGAT GMBH
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 EUROFINS SCIENTIFIC
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENTS
14.12 GENEDX, LLC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GENEFIRST LIMITED.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 ILLUMINA, INC
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 INTEGRATED DNA TECHNOLOGIES, INC.
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 MERIDIAN BIOSCIENCE, INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 PSOMAGEN
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 QIAGEN
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 SOPHIA GENETICS
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 TWIST BIOSCIENCE
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
TABLE 1 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC THIRD-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC KITS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC DRUG DISCOVERY AND DEVELOPMENT IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC AGRICULTURE & ANIMAL RESEARCH IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC DIAGNOSTICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC PERSONALIZED MEDICINE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC ACADEMIC & RESEARCH INSTITUTES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC HOSPITALS AND CLINICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC CLINICAL LABORATORIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC DIRECT TRADE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC RETAIL SALES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 31 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 32 ASIA-PACIFIC SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 33 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 34 ASIA-PACIFIC SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 35 ASIA-PACIFIC HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 36 ASIA-PACIFIC ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 37 ASIA-PACIFIC KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 42 CHINA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 43 CHINA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 44 CHINA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 45 CHINA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 46 CHINA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 47 CHINA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 48 CHINA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 49 CHINA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 50 CHINA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 51 CHINA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 52 CHINA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 53 JAPAN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 54 JAPAN SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 55 JAPAN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 56 JAPAN SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 57 JAPAN HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 58 JAPAN ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 59 JAPAN KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 60 JAPAN SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 61 JAPAN WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 JAPAN WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 63 JAPAN WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 64 INDIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 65 INDIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 66 INDIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 67 INDIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 68 INDIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 69 INDIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 70 INDIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 71 INDIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 72 INDIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 73 INDIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 74 INDIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 75 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 76 SOUTH KOREA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 77 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 78 SOUTH KOREA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 79 SOUTH KOREA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH KOREA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 81 SOUTH KOREA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 82 SOUTH KOREA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 83 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 87 AUSTRALIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 88 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 89 AUSTRALIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 90 AUSTRALIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 91 AUSTRALIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 92 AUSTRALIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 93 AUSTRALIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 94 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 95 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 96 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 97 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 98 SINGAPORE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 99 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 100 SINGAPORE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 101 SINGAPORE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 102 SINGAPORE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 103 SINGAPORE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 104 SINGAPORE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 105 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 106 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 107 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 108 THAILAND WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 109 THAILAND SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 110 THAILAND WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 111 THAILAND SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 112 THAILAND HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 113 THAILAND ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 114 THAILAND KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 115 THAILAND SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 116 THAILAND WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 117 THAILAND WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 118 THAILAND WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 119 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 120 INDONESIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 121 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 122 INDONESIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 123 INDONESIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 124 INDONESIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 125 INDONESIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 126 INDONESIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 127 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 128 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 129 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 130 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 131 PHILIPPINES SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 132 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 133 PHILIPPINES SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 134 PHILIPPINES HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 135 PHILIPPINES ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 136 PHILIPPINES KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 137 PHILIPPINES SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 138 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 139 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 140 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 141 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 142 MALAYSIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 143 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 144 MALAYSIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 145 MALAYSIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 146 MALAYSIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 147 MALAYSIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 148 MALAYSIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 149 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 150 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 151 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 152 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 153 VIETNAM SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 154 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 155 VIETNAM SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 156 VIETNAM HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 157 VIETNAM ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 158 VIETNAM KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 159 VIETNAM SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 160 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 161 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 162 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 163 REST OF ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 THE INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC WHOLE EXOME SEQUENCING (WES) MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET
FIGURE 15 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2021
FIGURE 16 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2021
FIGURE 20 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2021
FIGURE 24 LOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY END USER, 2021
FIGURE 28 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 32 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 36 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 37 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 40 ASIA PACIFIC WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.